Skip to main content
  • Sign in
  • Help
BOPA
  • Why join BOPA
  • Pricing
  • Education
    • BOPA Introduction to Cancer Course 2025
    • Courses and eLearning
    • SACT Verification Hub (Passport)
    • Resource Library
    • Cancer Hub
    • Education & Training Standards
    • Let’s Talk About SACT – a BOPA Podcast
  • About BOPA
    • About BOPA
    • Welcome to BOPA
    • Executive Committee
    • Subcommittees & working groups
    • Affiliated Groups
    • Specialist Advisory Groups
    • International Groups
    • BOPA Fellows
    • Corporate Membership
    • BOPA membership FAQs
  • Conference
    • Latest Conference 2025
    • Abstract Submission Opens 31st March
    • Past Symposiums / Conferences
  • News & Events
    • News
    • Events calendar
    • Submit event
  • Menu iconLCC
    • LCC
    • Cancer Hub
  • Join BOPA
Join BOPA
BOPA Join BOPA
  • Why join BOPA
  • Pricing
  • Education
    • BOPA Introduction to Cancer Course 2025
    • Courses and eLearning
    • SACT Verification Hub (Passport)
    • Resource Library
    • Cancer Hub
    • Education & Training Standards
    • Let’s Talk About SACT – a BOPA Podcast
  • About BOPA
    • About BOPA
    • Welcome to BOPA
    • Executive Committee
    • Subcommittees & working groups
    • Affiliated Groups
    • Specialist Advisory Groups
    • International Groups
    • BOPA Fellows
    • Corporate Membership
    • BOPA membership FAQs
  • Conference
    • Latest Conference 2025
    • Abstract Submission Opens 31st March
    • Past Symposiums / Conferences
  • News & Events
    • News
    • Events calendar
    • Submit event
  • Menu iconLCC
    • LCC
    • Cancer Hub
  • Join BOPA

Home

Resources

BOPA encourages its members to share helpful documents that can benefit other members.  BOPA respects the intellectual property of original authors and requires anyone who uses other members’ work to include an acknowledgment of, or reference to, the source in their version.

DISCLAIMER:
BOPA is not the author or owner of some of the documents published on our website.  BOPA as a professional interest group will share documents via its website that are of interest to BOPA members, but has no responsibility for use of the documents and for any recommendations within the documents so members must use these at their discretion. BOPA cannot accept responsibility for any errors or omissions or for any consequences from application of information in the documents attached and make no warranty, expressed or implicit with respect to the contents of this webpage. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site or document(s) downloaded from it.

Posters and abstracts on the BOPA website remain the property of the authors and anyone wishing to reference or share this work must contact the authors directly. Abstracts subsequently published in JOPP follow copyright rules from JOPP.

Last reviewed: 08/10/21 by Helen Flint

An evaluation of the service benefit of commencing Phesgo at The Clatterbridge Cancer Centre

Abstracts

View resources
Last reviewed: 18/10/21 by William Neill

A Service evaluation of capacity use (chair and treatment time) for metastatic colorectal cancer patients (mCRC) treated with EGFR therapies and chemotherapy at The Royal Marsden NHS Foundation Trust

Abstracts

View resources
Last reviewed: 08/10/21 by Nick Duncan

An investigation of the use of dexrazoxane as a cardioprotectant in UK Teenage and Young Adult (TYA) Cancer Centres

Abstracts

View resources
Last reviewed: 08/10/21 by Nicola Stoner

Thames Valley Cancer Alliance Cancer Pharmacy Team Workforce Benchmarking

Abstracts

View resources
Last reviewed: 08/10/21 by Nicola Stoner

Cancer Pharmacy Team Workforce Reconfiguration

Abstracts

View resources
Last reviewed: 08/10/21 by Wendy Ng

A Multi-Disciplinary Team Approach to managing Cancer Care Delivery during the COVID19 Pandemic

Abstracts

View resources
Last reviewed: 08/10/21 by Bastiaan Buijtenhuijs

Evaluation of pharmacy staff resource requirements for new health technology appraisal approved SACT.

Abstracts

View resources
Last reviewed: 22/03/23 by Sana Mahmood

Multi centre retrospective evaluation of Paclitaxel hypersensitivity reactions in the absence of H2 antagonist pre-medication

Abstracts

View resources
Last reviewed: 08/10/21 by Nick Duncan

An investigation of the impact of timing of melphalan administration on neutrophil engraftment and hospitalisation post autologous stem cell transplant for multiple myeloma

Abstracts

View resources
Last reviewed: 08/10/21 by Wendy Ng

Preference of Subcutaneous Trastuzumab and Pertuzumab (Phesgo) Versus Conventional Intravenous Infusions in Breast Cancer Patients

Abstracts

View resources
Last reviewed: 08/10/21 by Lois Pollock

South East of Scotland Cancer Network (SCAN) Systemic Anti-Cancer Therapy (SACT) Capacity and Future Modelling Tool

Abstracts

View resources
Last reviewed: 08/10/21 by Jenna Poon

Reducing parenteral systemic anti-cancer therapy (SACT) wastage in chemotherapy day care unit

Abstracts

View resources

Filter for resources

  • Types

  • Tags

  • Reset

Previous 1 … 43 44 45 … 109 Next
BOPA logo
  • Why join BOPA
  • Pricing/Join
  • Conference 2024
  • Education
  • About
  • News & Events
  • Help
  • Go to LinkedIn
  • Go to Twitter
  • Go to Facebook
  • Go to Instagram
  • Go to Bluesky

© Copyright 2025 British Oncology Pharmacy Association.
Registered Charity No. 1065026

  • Privacy Policy
  • T&Cs Website
  • T&Cs Membership
  • Cookies
  • Contact
Designed and developed by Rouge
Our website uses cookies to distinguish you from other users of our website. This helps us to provide you with a good experience when you browse our website and also allows us to improve our site. By continuing to browse the site, you are agreeing to our use of cookies.